BD0408445
N-(4-Cyanophenyl)-2-(4-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)phenoxy)acetamide , 98% , 264622-58-4
Synonym(s):
8-[4-[((4-Cyanophenyl)carbamoylmethyl)oxy]phenyl]-1,3-di(n-propyl)xanthine hydrate
| Pack Size | Price | Stock | Quantity |
| 5mg | RMB1146.40 | In Stock |
|
| 10mg | RMB1655.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Density | 1.38±0.1 g/cm3(Predicted) |
| storage temp. | room temp |
| solubility | DMSO: soluble >10mg/mL |
| pka | 8.24±0.70(Predicted) |
| form | solid |
| color | off-white |
Description and Uses
MRS 1754 acts as an adenosine receptor antagonist which displays bronchospasmolytic activity, applicable to treatments involving respiratory disorders.
Safety
| Symbol(GHS) |  GHS05 |
| Signal word | Danger |
| Hazard statements | H314-H290 |
| Precautionary statements | P501-P260-P234-P264-P280-P390-P303+P361+P353-P301+P330+P331-P363-P304+P340+P310-P305+P351+P338+P310-P406-P405 |
| Safety Statements | 22-24/25 |
| WGK Germany | 3 |
